On January 2, 2025, China’s National Medical Products Administration (NMPA) granted conditional approval to Platinum Life Excellence Biotech Co. Ltd.’s amimestrocel injection (hUC-MSC PLEB-001), marking a significant milestone in the country’s medical and biotechnological advancements. The product is being marketing under the brand name Ruibosheng. This approval designates it as China’s first human umbilical cord-derived mesenchymal stem cell (hUC-MSC) therapy, offering a promising treatment option for steroid-refractory acute graft-versus-host disease (GVHD), a serious and often fatal complication following stem cell transplants. [Read more…]
7 Tactical Ways to Assess Which Stem Cell Procedures Might Work
Stem cell research used to be controversial specifically because of the attention given to embryonic stem cells, which are derived from human embryos. Thankfully, very little research is done on embryonic stem cells anymore, because there are now better, non-controversial alternatives available for research and clinical use. These alternatives include induced pluripotent stem cells (derived from mature human cells) and adult stem cells, which can be sourced from the blood, bone marrow, and fat tissue, for example. [Read more…]
Updates on Stem Cells for Cystic Fibrosis Treatment
In 1938, American doctor Dorothy Anderson noted a condition in which individuals suffered damage to the pancreas, calling it cystic fibrosis. Other physicians of her time and even earlier noted symptoms such as salty skin and thickened mucus, making it hard to breathe and function normally. While in recent decades, scientists have gained a much better understanding of what cystic fibrosis does to the body, they haven’t had nearly as much luck in finding an effective course of cystic fibrosis treatment. Luckily, that may soon change. [Read more…]
Decoding Biological Aging: Is Age Just a Number?
The relentless march of time is an inescapable fact, but its effects on our overall well-being are profound and intricate. Referred to by some experts as the “master disease”, aging is more than merely growing older. It represents the functional decline of a living organism over time. This article probes into the multifaceted nature of biological aging, its repercussions, and the innovative ways in which science is demystifying and even countering its challenges. [Read more…]
Nucleus Biologics Becomes First Custom Cell Culture Media Company to Achieve EXCiPACT Certification for the Manufacture of Excipient GMP Quality Cell Culture Media, Supplements, and Buffers
San Diego, CA, January 9, 2025 – Nucleus Biologics, a leader in precision cell culture media development, is proud to announce that it has achieved an industry-leading quality milestone. It has received EXCiPACT certification for Pharmaceutical Excipients and Pharmaceutical Auxiliary Materials (PAMs) and ISO 9001 certification from SGS. This Excipient GMP certification will better support the cell culture media, buffers, reagents, and supplements needs for our cell and gene therapy customers. This certification, in addition to our ISO 13485 certification, underscores Nucleus Biologics’ commitment to delivering the highest quality products that meet the most stringent safety, consistency, and compliance requirements of the biopharmaceutical industry. [Read more…]
- « Previous Page
- 1
- …
- 66
- 67
- 68
- 69
- 70
- …
- 334
- Next Page »




